Last reviewed · How we verify

Lidocaine tetracaine cream

Cutia Therapeutics(Wuxi)Co.,Ltd · Phase 3 active Small molecule

Lidocaine tetracaine cream is a Local anesthetic combination Small molecule drug developed by Cutia Therapeutics(Wuxi)Co.,Ltd. It is currently in Phase 3 development for Topical anesthesia for dermatological procedures, Local pain relief for skin conditions. Also known as: test drug:CU-30101, control drug:Pliaglis.

Lidocaine and tetracaine are local anesthetics that block sodium channels in nerve cell membranes to inhibit pain signal transmission.

Lidocaine and tetracaine are local anesthetics that block sodium channels in nerve cell membranes to inhibit pain signal transmission. Used for Topical anesthesia for dermatological procedures, Local pain relief for skin conditions.

At a glance

Generic nameLidocaine tetracaine cream
Also known astest drug:CU-30101, control drug:Pliaglis
SponsorCutia Therapeutics(Wuxi)Co.,Ltd
Drug classLocal anesthetic combination
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

This combination cream works by penetrating the skin and numbing nerve endings through reversible blockade of voltage-gated sodium channels. Lidocaine and tetracaine together provide rapid onset and prolonged duration of local anesthesia, making the combination suitable for topical pain relief in dermatological procedures or conditions requiring surface anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lidocaine tetracaine cream

What is Lidocaine tetracaine cream?

Lidocaine tetracaine cream is a Local anesthetic combination drug developed by Cutia Therapeutics(Wuxi)Co.,Ltd, indicated for Topical anesthesia for dermatological procedures, Local pain relief for skin conditions.

How does Lidocaine tetracaine cream work?

Lidocaine and tetracaine are local anesthetics that block sodium channels in nerve cell membranes to inhibit pain signal transmission.

What is Lidocaine tetracaine cream used for?

Lidocaine tetracaine cream is indicated for Topical anesthesia for dermatological procedures, Local pain relief for skin conditions.

Who makes Lidocaine tetracaine cream?

Lidocaine tetracaine cream is developed by Cutia Therapeutics(Wuxi)Co.,Ltd (see full Cutia Therapeutics(Wuxi)Co.,Ltd pipeline at /company/cutia-therapeutics-wuxi-co-ltd).

Is Lidocaine tetracaine cream also known as anything else?

Lidocaine tetracaine cream is also known as test drug:CU-30101, control drug:Pliaglis.

What drug class is Lidocaine tetracaine cream in?

Lidocaine tetracaine cream belongs to the Local anesthetic combination class. See all Local anesthetic combination drugs at /class/local-anesthetic-combination.

What development phase is Lidocaine tetracaine cream in?

Lidocaine tetracaine cream is in Phase 3.

What are the side effects of Lidocaine tetracaine cream?

Common side effects of Lidocaine tetracaine cream include Skin irritation or erythema, Contact dermatitis, Allergic reaction.

What does Lidocaine tetracaine cream target?

Lidocaine tetracaine cream targets Voltage-gated sodium channels and is a Local anesthetic combination.

Related